Johnson and Johnson

CDC Amends EUA to Include 4th Dose for Immunocompromised

Yesterday, the CDC updated their guidelines on COVID-19 vaccines for those who are “moderately and severely” immunocompromised. People who fall into this category include those living with autoimmune disease, who are currently on therapies such as high-dose corticosteroids and other drugs that suppress the immune system.

Read More »

CDC Endorses Boosters for Moderna and J&J Vaccines

Last night, the CDC endorsed the Advisory Committee on Immunization Practices’ (ACIP) recommendation in favor of booster doses for the Moderna and Johnson & Johnson (J&J) vaccines. The Moderna vaccine has been endorsed for use as a booster vaccine (at least 6 months after the primary series) in the following populations:

Read More »

FDA Authorizes Use of J&J and Moderna Boosters, as well as Mix-and-Matching

Last night, the FDA issued a news release on the use of the Moderna and Johnson & Johnson (J&J) vaccines, including implementation of the mix-and-match method for boosters. The agency amended the emergency use authorization (EUA) for COVID-19 vaccines to allow for booster doses, adding that, “the use of a single booster dose of the Moderna COVID-19 Vaccine that may be administered at least 6 months after completion of the primary series” to individuals:

Read More »